🇺🇸 FDA
Patent

US 9233169

Oligomer-bis-chromonyl compound conjugates

granted A61KA61K31/353A61K47/60

Quick answer

US patent 9233169 (Oligomer-bis-chromonyl compound conjugates) held by Nektar Therapeutics expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/353, A61K47/60, A61P, A61P11/06